Related Experiment Video
Updated: Dec 4, 2025
07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.7K
Novel Methylation Patterns Predict Outcome in Uveal Melanoma
Sarah Tadhg Ferrier1, Julia Valdemarin Burnier1,2,3
1Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
Life (Basel, Switzerland)
|October 23, 2020
Summary
Epigenetic methylation patterns in uveal melanoma (UM) can predict patient prognosis. Identifying these methylation changes offers new biomarkers for risk stratification and potential therapeutic targets for this common eye cancer.
Area of Science:
- Oncology
- Epigenetics
- Ophthalmology
Background:
- Uveal melanoma (UM) is the most common primary intraocular tumor in adults.
- Despite effective local treatments, 50% of UM patients develop metastasis, necessitating improved prognostic tools and therapeutic targets.
- Epigenetic alterations, specifically DNA methylation, are implicated in cancer progression, yet their role in UM prognosis remains understudied.
Purpose of the Study:
- To identify DNA methylation events associated with uveal melanoma (UM) prognosis.
- To explore the potential of methylation patterns as prognostic indicators and therapeutic targets in UM.
Main Methods:
- Utilized matched clinical, genetic, and methylation data from 80 UM cases from The Cancer Genome Atlas (TCGA).
- Applied hierarchical clustering to identify methylation patterns and correlated these with tumor characteristics, genomic aberrations, and patient survival outcomes.
- Analyzed differential methylation of specific genes, including NFIA, HDAC4, and IL12RB2.
Main Results:
- Hierarchical clustering identified two distinct methylation-based groups that effectively separated high-risk and low-risk UM cases.
- Significant differences in patient survival (p < 0.0001) were observed between the two identified groups.
- Key genes such as NFIA, HDAC4, and IL12RB2 showed major methylation differences between the risk groups, correlating with known prognostic factors.
Conclusions:
- Identified methylation patterns serve as potential novel prognostic indicators for uveal melanoma (UM).
- DNA methylation changes significantly predict UM patient outcomes and highlight the potential for epigenetic therapies.
- Differentially methylated loci may function as biomarkers for therapeutic response and could inform strategies to reduce metastatic potential.
